Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

[1]  K. Jacobson,et al.  Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. , 1991, The Journal of pharmacology and experimental therapeutics.

[2]  J. Phillis,et al.  Adenosine and Adenine Nucleotides As Regulators of Cellular Function , 1991 .

[3]  U. Ungerstedt,et al.  Theophylline concentration in the extracellular space of the rat brain: measurement by microdialysis and relation to behaviour. , 1990, European journal of pharmacology.

[4]  D J Greenblatt,et al.  Caffeine‐induced behavioural stimulation is dose‐ and concentration‐dependent , 1990, British journal of pharmacology.

[5]  S. Freedman,et al.  Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding. , 1989, European journal of pharmacology.

[6]  P F Morgan,et al.  Potent convulsant actions of the adenosine receptor antagonist, xanthine amine congener (XAC). , 1989, Life sciences.

[7]  J. Daly,et al.  3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. , 1988, Life sciences.

[8]  L. Dykstra,et al.  Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. , 1987, The Journal of pharmacology and experimental therapeutics.

[9]  R. Wurtman,et al.  Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline. , 1987, The Journal of pharmacology and experimental therapeutics.

[10]  K. Jacobson,et al.  [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Lu,et al.  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. , 1986, Molecular pharmacology.

[12]  T. Nowak,et al.  Nimodipine levels in gerbil brain following parenteral drug administration. , 1985, Journal of neurosurgery.

[13]  K. Jacobson,et al.  Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. , 1985, Journal of medicinal chemistry.

[14]  L. Heller,et al.  Inhibition of rat ventricular automaticity by adenosine. , 1985, The American journal of physiology.

[15]  J. Daly,et al.  1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors. , 1985, Journal of medicinal chemistry.

[16]  S. Snyder,et al.  Adenosine receptors and the actions of methylxanthines , 1981, Trends in Neurosciences.

[17]  S H Snyder,et al.  Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. , 1981, Life sciences.

[18]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.